Based in Ireland.
YE25 turnover of circa 235,000, with an adjusted EBITDA in excess of 185,000.
Benefits from equipment and fixed assets valued at circa 334,000, supporting polymer R&D, product development and pilot manufacturing.
Supports its clients to rapidly develop, prototype, optimise, and validate new products and formulations prior to full commercial scale-up, reducing development timelines, technical risk, and production costs.
Operates with a lean, highly experienced team in place, which has enabled it to become a leading provider of its niche services.
Typically works with six to eight clients annually, with its longest-standing key client in place for seven years to date.
Serves an international client base, including those in the packaging, medical, pharmaceutical, and industrial sectors.
The shareholder is willing to remain in a suitable position following the sale to facilitate a smooth transition and aid with future growth.
Operates from leasehold premises, rented for circa 25,000 per annum.
Offered for sale to enable the shareholder to realise the value of the business while supporting the next phase of growth under a strategic growth owner.
Offers invited.
- Asking Price:
- Undisclosed
- Turnover:
- Undisclosed
- Net Profit:
- Undisclosed
Property Information
- Property:
-
Leasehold
